Searchable abstracts of presentations at key conferences in endocrinology

ea0012p85 | Pituitary | SFE2006

“Cinderella’s Unhappy”: an objective measure of the psychological impact of pituitary conditions

Klingbeil Liane , Jackson S , Morris M , Ashley K

ObjectiveThis explorative study is concerned with assessing the psychosocial impact of living with a pituitary condition. In collaboration with the Pituitary Foundation, who work to understand and represent the experiences of patients, this study explored the psychosocial issues that are evident for and identified by patients with a pituitary condition (anxiety, depression and appearance related distress).Method<p class="abstex...

ea0011oc16 | Steroids and reproductive endocrinology | ECE2006

17β-estradiol regulates pituitary AnxA1 expression and externalization in vivo and in vitro

Davies EL , Christian HC , Omer S , Buckingham JC , Morris JF

Annexin A1 (AnxA1) acts as a mediator of glucocorticoid (GC) actions in neuroendocrine systems. In the anterior pituitary Anx-1 is expressed mainly by folliculostellate (FS) cells and mediates the early-delayed feedback inhibition exerted by GCs on release of ACTH and other pituitary hormones. GC cause the externalization of AnxA1. The stress responsiveness of the female rat hypothalamo-pituitary-adrenal system varies with the estrous cycle, with increased CORT release in resp...

ea0011oc35 | Neuroendocrinology and neoplasia | ECE2006

Immunocytochemical colocalisation of hormones in the human fetal pituitary

Chirculescu ARM , Badiu C , Morris JF , Coculescu M

Colocalisation of hormones in the adult human pituitary has been demonstrated only for growth hormone (GH) and prolactin (PL) and only for adenomatous tissue. We have investigated whether colocalization occurs earlier in ontogenesis. Pituitaries from male human fetuses of 16–22 weeks gestational age fixed by immersion in 4% buffered formaldehyde and embedded in LR Gold were processed for immunocytochemical double labelling with GH/FSH or GH/LH anti-rat and anti-human prim...

ea0011p92 | Clinical case reports | ECE2006

Purely adrenaline-secreting phaeochromocytoma: a classical presentation of a rare entity

Merghani A , Darzy KH , Morris D , Carpenter R , Deaner A , Monson JP

A provisional diagnosis of paroxysmal atrial fibrillation with normal blood pressure and echocardiogram was made in a 58 years old man. He described ‘funny turns’ on standing during which he would become sweaty, tremulous with palpitations and headache and facial flushing preceded by pallor. The patient was otherwise fit and healthy with a BMI of 27.3 kg/m2; he used to drink about 15 pints of beer per week and smoke 11 cigarettes daily for the last 40 year...

ea0011p576 | Neuroendocrinology and behaviour | ECE2006

Structural analysis of somatotrophs and lactotrophs in annexin 1 null mice

Afzal T , Morris JF , Buckingham JC , Christian HC

Annexin 1 (ANXA1) is a member of the annexin family of phospholipid- and calcium- binding proteins with a well-demonstrated role in the inhibitory actions of glucocorticoids on the release of ACTH, TSH, GH and PRL from the anterior pituitary. Consistent with these findings plasma PRL content is raised in male ANXA1 null mice vs wild-type controls (Cover et al Endocrine Abstracts 8, P69). Here we test the hypothesis that because ANXA1 mediates some of the inhibitory actions of ...

ea0010oc11 | Thyroid and pituitary | SFE2005

Mortality and vascular outcomes in the thyroid population: an observational study comparing relative levels of mortality and morbidity using the record linkage of patient level datasets

Flynn R , MacDonald T , Morris A , Jung|G##Leese R

Objective: To describe the mortality and vascular morbidity in patients after treatment for hyperthyroidism and hypothyroidism.Method: We constructed an electronic database using record linkage of a community thyroid follow-up register, radioiodine database, regional biochemistry, regional prescribing database, hospital admissions and regional death certification. This was made possible by a unique patient identifier used locally for all healthcare episo...

ea0010p56 | Pituitary | SFE2005

Regulation of anterior pituitary Anx-1 during the estrus cycle of the rat

Davies E , Christian H , Buckingham J , Morris J

Annexin-1 (Anx-1), a 37 kDa protein, is a member of the super-family of Ca2+and phospholipid-binding annexin proteins and acts as a mediator of glucocorticoid (GC) action in the host defence and neuroendocrine systems. In the anterior pituitary Anx-1 is expressed mainly by folliculostellate (FS) cells and mediates the early-delayed feedback inhibition exerted by GCs on the release of ACTH and other pituitary hormones.The stress responsiveness ...

ea0010p59 | Pituitary | SFE2005

Inhibitors of the ABCA1 transporter affect annexin 1 release in the TtT/GF folliculostellate cell line

Payne J , Morris J , Solito E , Buckingham J

Acknowledgements: This work was generously supported by the Wellcome TrustAnnexin 1 (ANXA1) plays an important role in mediating the negative feedback effects of glucocorticoids on the HPA axis. It is released from non-secretory folliculostellate (FS) cells by glucocorticoids and acts locally to suppress ACTH release from corticotrophs. Previous studies suggest that the steroid-induced translocation of ANXA1 across the FS cell membrane is effected via me...

ea0009oc22 | Oral Communication 3: Neuroendocrinology | BES2005

Modulators of the SUR2B/Kir6.1 ATP-sensitive K+ channel regulate annexin 1 release in the TtT/GF folliculostellate cell line

Payne J , Morris J , Solito E , Buckingham J

Annexin 1 (ANXA1) plays an important role in mediating the negative feedback effects of glucocorticoids on the HPA axis. In the anterior pituitary gland ANXA1 is localised mainly to the non-secretory folliculostellate (FS) cells. It is released from these cells by glucocorticoids and acts locally to suppress ACTH release from corticotrophs. Functional and histological studies suggest that the steroid-induced translocation of ANXA1 across the FS cell membrane is effected via me...

ea0009p127 | Endocrine tumours and neoplasia | BES2005

Does Annexin-1 have a biological function in the adrenal gland?

Omer S , Davies E , Christian H , Buckingham J , Morris J

Annexin-1 (Anx-1), a 37kDa protein, is a member of the super-family of Ca2+- and phospholipid-binding annexin proteins and acts as a mediator of glucocorticoid (GC) action in the host defence and neuroendocrine systems. In the anterior pituitary Anx-1 is expressed mainly by folliculostellate (FS) cells and mediates the early delayed feedback inhibition exerted by GCs on the release of ACTH and other pituitary hormones.The role of Anx-1 in the ...